9:41
mitosense.com
Screenshot of mitosense.com
mitosense.com favicon

mitosense.com

13 technologies
VerifiedVisit$0M113 Tech
Deep Dive

MitoSense: The Mitochondrial Revolution

Why this tiny biotech is betting big on cellular powerhouses to cure neurodegeneration

MitoSense isn't just another biotech startup—it's a strategic bet on the mitochondria, the microscopic power plants of our cells. With exclusive licensing to technology that could replenish mitochondrial function, they're targeting the root cause of ALS, Alzheimer's, and Parkinson's, not just the symptoms.

1
employee (publicly listed)
$200K
annual revenue
0
monthly website visits
3
social profiles

"They're not building a drug—they're building a mitochondrial replacement engine, and the market has barely woken up to it."

The Stealth Play

With just one employee and zero public funding rounds, MitoSense operates like a black box. The $200K revenue suggests early-stage partnerships or grants, but their real value lies in exclusive patent-pending technology. This isn't a company burning cash on marketing—it's a lab-first operation where IP is king.

The Market Gap

While big pharma chases protein aggregation (amyloid plaques in Alzheimer's, alpha-synuclein in Parkinson's), MitoSense attacks the energy crisis behind them. Mitochondrial dysfunction is a common thread in neurodegeneration, and if their replenishment tech works, it could be platformable across multiple diseases. That's the scale-up potential.

Van Hipp, the Chairman, brings serious credibility. As a former US Army Special Forces officer and biotech veteran, he doesn't waste time on fluff. His involvement signals this isn't a science experiment—it's a strategic venture with military-grade discipline. The tech stack on their site (React, Bootstrap, Zendesk) is clean but functional, suggesting they're focused on science, not flashy UI.

  • Exclusive, patent-pending mitochondrial replenishment technology
  • Targets root cause (energy failure) vs. symptom management
  • Platform potential across neurodegenerative disorders
  • Chairman with military and biotech leadership experience
  • Zero public funding—likely bootstrapped or grant-funded
No public clinical data yet
Exclusive IP in a massive, untapped market
No disclosed funding or investors
Clear scientific focus on mitochondrial dysfunction
Minimal web presence and traffic
Platform potential beyond single-disease applications
Single employee listed publicly
Leadership with execution experience

The Silent Giant in the Making

MitoSense is either a hidden gem or a ghost ship. With mitochondrial dysfunction linked to 90% of neurodegenerative diseases, if their tech hits, the payoff could be monumental. But until they show data, it's a high-risk, high-reward bet for the brave.

What tech stack does Mitosense use?

14 detected
Error Tracking1
CMS1
Customer Support1
Web Standards2
Build Tools1
CSS Frameworks1
JavaScript Libraries2
Frontend Frameworks1
Tracking & Analytics1
G
Google Analytics

How much traffic does Mitosense get?

Traffic & Engagement

0.0
Pages/Visit
0:00
Avg. Duration
0%
Bounce Rate
Monthly Traffic Trend+0%
0
Oct 2025
Oct
0
Nov 2025
Nov
0
Dec 2025
Dec

How is Mitosense's SEO?

Open Graph Image

OG Image preview
og:image

https://static.wixstatic.com/media/9b5f81_825ccef123944e0cb6d98ade24deef52%7Emv2.png/v1/fit/w_2500,h_1330,al_c/9b5f81_825ccef123944e0cb6d98ade24deef52%7Emv2.png

Meta Tags

title65 chars

Harnessing the Power of Mitochondria to Fight Disease | MitoSense

description207 chars

MitoSense is an R&D company with exclusively licensed and patent pending technology to replenish mitochondria to fight disease, including neurodegenerative disorders such as ALS, Alzheimer’s and Parkinson’s.

languageEN

H1 Tags

h1The future of cell therapy

Schema Types

WebSite

Who works at Mitosense?

Loading leads...

What do customers think of Mitosense?

No Trustpilot reviews available for this company.

Frequently Asked Questions about Mitosense

What is Mitosense's Revenue?
Mitosense generates approximately $0M in annual revenue. With 1 employees, that's $155,000 per employee.
What does Mitosense do?
MitoSense is an R&D company with exclusively licensed and patent pending technology to replenish mitochondria to fight disease, including neurodegenerative disorders such as ALS, Alzheimer’s and Parkinson’s.
How fast is Mitosense growing?
Mitosense employee count has changed by 0% year over year.
What technologies does Mitosense use?
Mitosense uses 13 technologies across their website including Fonts, Error Tracking, CMS. Key technologies include Font Awesome, Sentry, Wix.
Who are Mitosense's competitors?
Mitosense's main competitors include Ultivue, Ohana Biosciences, Matterworks, Tango Therapeutics, Gelesis. These companies operate in similar markets and compete for the same customer base.

Export Data

Unlock all exports

Download CSVs, JSONs & full reports

How to contact Mitosense?

What are Mitosense's key pages?

Export mitosense.com Data

Download the complete tech stack, analytics, leads, and company data for mitosense.com in JSON or CSV format. Use it for your sales pipeline, competitive analysis, or research.

Raw JSON Data

Click "Show" to view the raw API response data

About mitosense.com

MitoSense is an R&D company with exclusively licensed and patent pending technology to replenish mitochondria to fight disease, including neurodegenerative disorders such as ALS, Alzheimer’s and Parkinson’s.

Company Overview

mitosense.com
Website
0
Monthly Visitors
13
Technologies

mitosense.com Key Pages

Contact mitosense.com

Technology Stack

mitosense.com uses 13 technologies across their website including Font Awesome, Sentry, Wix, and more.

Fonts

Font Awesome

Error Tracking

Sentry

CMS

Wix

Customer Support

Zendesk

Performance

Lazy Loading, Priority Hints

Web Standards

Twitter Cards, RSS

Traffic & Audience

0
Monthly Visits
0%
Bounce Rate
0.0
Pages/Visit
0:00
Avg. Duration

mitosense.com receives approximately 0 monthly visitors. The website has a bounce rate of 0% with visitors viewing an average of 0.0 pages per visit. Users spend an average of 0:00 on the site.

Frequently Asked Questions

What is mitosense.com?
MitoSense is an R&D company with exclusively licensed and patent pending technology to replenish mitochondria to fight disease, including neurodegenerative disorders such as ALS, Alzheimer’s and Parkinson’s.
What technologies does mitosense.com use?
mitosense.com uses 13 technologies including Font Awesome, Sentry, and 7 more. View the full tech stack analysis above.
How do I contact mitosense.com?
You can contact mitosense.com through their contact page.
What are mitosense.com's social media accounts?
mitosense.com is active on twitter, facebook, linkedin. You can find links to all their social media profiles in the social section above.
How popular is mitosense.com?
mitosense.com receives approximately 0 monthly visitors.

Related Searches

mitosense.com pricingmitosense.com reviewsmitosense.com alternativesmitosense.com loginmitosense.com careerswhat is mitosense.commitosense.com tech stackmitosense.com contactmitosense.com vs competitorsmitosense.com featureshow to use mitosense.commitosense.com integrations

This page provides publicly available information about mitosense.com. Data is collected from various public sources and may not always be up to date. For the most accurate information, please visit mitosense.com directly at https://mitosense.com.